Antibodies against non-catalytic B subunit of factor XIII inhibit activation of factor XIII and fibrin crosslinking.

Anti-FXIII-B antibodies binding to the A2B2 heterotetramer and FXIII-B inhibited FXIII activation and its crosslinking function despite being directed against its non-catalytic subunit (FXIII-B).